Hence, we designed a series of experiments to investigate the correlation between the progression of NSCLC and the role of PD‐L1 in TAM/M2 polarization, aiming to seek new clinical immunotherapy methods for NSCLC and improve the survival rate of NSCLC patients. The gene discussed is CD274; the disease is non-small cell lung carcinoma.